Toward the first drug to treat a rare, lethal liver cancer

Model suggests surgery should precede chemotherapy for select patients with ovarian cancer

Histopathology-driven artificial intelligence predicts TMB-H colorectal cancer

New theranostic approach joins radiopharmaceuticals and nanoparticles to kill cancer cells